Ohio Medicaid Laboratory Testing Policies
F2019: Flow Cytometry - Effective Date: 12-01-2023
F2019: Flow Cytometry - Effective Date: 04-01-2025
G2002: Cervical Cancer Screening - Effective Date: 05-01-2024
G2002: Cervical Cancer Screening - Effective Date: 04-01-2025
G2005: Vitamin D Testing - Effective Date: 06-01-2024
G2005: Vitamin D Testing - Effective Date: 06-01-2025
G2006: Diabetes Mellitus Testing - Effective Date: 08-01-2024
G2006: Diabetes Mellitus Testing - Effective Date: 06-01-2025
G2007: Prostate Biopsies Specimen Analysis - Effective Date: 05-01-2024
G2007: Prostate Biopsy Specimen Analysis - Effective Date: 04-01-2025
G2008: Prostate Specific Antigen (PSA) Testing - Effective Date: 12-01-2023
G2008: Prostate Specific Antigen (PSA) Testing - Effective Date: 08-01-2024
G2009: Preventive Screening in Adults - Effective Date: 11-01-2023 to 11-30-2023
G2011: Diagnostic Testing of Iron Homeostasis & Metabolism - Effective Date: 06-01-2024
G2011: Diagnostic Testing of Iron Homeostasis & Metabolism - Effective Date: 06-01-2025
G2013: Testosterone - Effective Date: 06-01-2024
G2013: Testosterone - Effective Date: 06-01-2025
G2014: Vitamin B12 and Methylmalonic Acid Testing - Effective Date: 06-01-2024
G2014: Vitamin B12 and Methylmalonic Acid Testing - Effective Date: 06-01-2025
G2022: Biomarker Testing for Autoimmune Rheumatic Disease - Effective Date: 12-01-2023
G2022: Biomarker Testing for Autoimmune Rheumatic Disease - Effective Date: 08-01-2024
G2023: Pre Operative Testing - Effective Date: 07-01-2021 to 04-30-2022
G2031: Allergen Testing - Effective Date: 12-01-2023
G2031: Allergen Testing - Effective Date: 08-01-2024
G2035: Prenatal Screening (Nongenetic) - Effective Date: 02-01-2024
G2035: Prenatal Screening (Nongenetic) - Effective Date: 04-01-2025
G2036: Hepatitis Testing - Effective Date: 06-01-2024
G2036: Hepatitis Testing - Effective Date: 04-01-2025
G2042: Pediatric Preventive Screening - Effective Date: 11-01-2022 to 09-30-2023
G2043: Celiac Disease Testing - Effective Date: 05-01-2024
G2043: Celiac Disease Testing - Effective Date: 04-01-2025
G2044: Helicobacter pylori Testing - Effective Date: 12-01-2023
G2044: Helicobacter pylori Testing - Effective Date: 08-01-2024
G2045: Thyroid Disease Testing - Effective Date: 12-01-2023
G2045: Thyroid Disease Testing - Effective Date: 04-01-2025
G2048: Biochemical Markers of Alzheimer Disease and Dementia - Effective Date: 05-01-2024
G2048: Biochemical Markers of Alzheimer Disease and Dementia - Effective Date: 04-01-2025
G2050: Cardiovascular Disease Risk Assessment - Effective Date: 08-01-2024
G2050: Cardiovascular Disease Risk Assessment - Effective Date: 04-01-2025
G2051: Bone Turnover Markers Testing - Effective Date: 05-01-2024
G2051: Bone Turnover Markers Testing - Effective Date: 04-01-2025
G2055: Prenatal Screening for Fetal Aneuploidy - Effective Date: 11-01-2022 to 02-28-2023
G2056: Diagnosis of Idiopathic Environmental Intolerance - Effective Date: 08-01-2024
G2056: Diagnosis of Idiopathic Environmental Intolerance - Effective Date: 06-01-2025
G2059: Epithelial Cell Cytology in Breast Cancer Risk Assessment - Effective Date: 05-01-2024
G2059: Epithelial Cell Cytology in Breast Cancer Risk Assessment - Effective Date: 04-01-2025
G2060: Fecal Analysis in The Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing - Effective Date: 05-01-2024
G2060: Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing - Effective Date: 04-01-2025
G2061: Fecal Calprotectin Testing in Adults - Effective Date: 05-01-2024
G2061: Fecal Calprotectin Testing in Adults - Effective Date: 04-01-2025
G2063: Testing for Diagnosis of Active or Latent Tuberculosis - Effective Date: 05-01-2024
G2063: Testing for Diagnosis of Active or Latent Tuberculosis - Effective Date: 04-01-2025
G2098: Immune Cell Function Assay - Effective Date: 05-01-2024
G2098: Immune Cell Function Assay - Effective Date: 06-01-2025
G2099: Intracellular Micronutrient Analysis - Effective Date: 12-01-2023
G2099: Intracellular Micronutrient Analysis - Effective Date: 08-01-2024
G2100: In Vitro Chemoresistance and Chemosensitivity Assays - Effective Date: 05-01-2024
G2100: In Vitro Chemoresistance and Chemosensitivity Assays - Effective Date: 04-01-2025
G2105: Immunopharmacologic Monitoring of Therapeutic Serum Antibodies - Effective Date: 05-01-2024
G2105: Immunopharmacologic Monitoring of Therapeutic Serum Antibodies - Effective Date: 04-01-2025
G2107: Measurement of Thromboxane Metabolites for ASA Resistance - Effective Date: 05-01-2024 to 01-31-2025
G2110: Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease - Effective Date: 05-01-2024
G2110: Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease - Effective Date: 04-01-2025
G2113: Oral Cancer Screening and Testing - Effective Date: 02-01-2024
G2113: Oral Cancer Screening and Testing - Effective Date: 04-01-2025
G2115: Metabolite Markers of Thiopurines Testing - Effective Date: 05-01-2024
G2115: Metabolite Markers of Thiopurines Testing - Effective Date: 04-01-2025
G2119: Diagnostic Testing of Influenza - Effective Date: 05-01-2024
G2119: Diagnostic Testing of Influenza - Effective Date: 04-01-2025
G2120: Salivary Hormone Testing - Effective Date: 12-01-2023
G2120: Salivary Hormone Testing - Effective Date: 08-01-2024
G2121: Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease - Effective Date: 05-01-2024
G2121: Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease - Effective Date: 04-01-2025
G2123: Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases - Effective Date: 05-01-2024
G2123: Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases - Effective Date: 04-01-2025
G2124: Serum Tumor Markers for Malignancies - Effective Date: 06-01-2024
G2124: Serum Tumor Markers for Malignancies - Effective Date: 04-01-2025
G2125: Urinary Tumor Markers For Bladder Cancer - Effective Date: 12-01-2023
G2125: Urinary Tumor Markers for Bladder Cancer - Effective Date: 08-01-2024
G2127: Vectra DA Blood Test for Rheumatoid Arthritis - Effective Date: 11-01-2022 to 11-30-2023
G2130: ST2 Assay for Chronic Heart Failure - Effective Date: 01-01-2023 to 11-30-2023
G2132: Erectile Dysfunction - Effective Date: 01-01-2023 to 11-30-2023
G2133: ZIKA Virus Risk Assessment - Effective Date: 11-01-2022 to 11-30-2023
G2138: Evaluation of Dry Eyes - Effective Date: 12-01-2023
G2138: Evaluation of Dry Eyes - Effective Date: 08-01-2024
G2143: Lyme Disease Testing - Effective Date: 12-01-2023
G2143: Lyme Disease Testing - Effective Date: 08-01-2024
G2149: Pathogen Panel Testing; efd 04-01-2025
G2149: Pathogen Panel Testing - Effective Date: 06-01-2025
G2150: Biomarkers for Myocardial Infarction and Chronic Heart Failure - Effective Date: 05-01-2024
G2150: Biomarkers for Myocardial Infarction and Chronic Heart Failure - Effective Date: 04-01-2025
G2151: Serum Testing for Evidence of Mild Traumatic Brain Injury - Effective Date: 04-01-2025
G2153: Pancreatic Enzyme Testing for Acute Pancreatitis - Effective Date: 02-01-2024
G2153: Pancreatic Enzyme Testing for Acute Pancreatitis - Effective Date: 04-01-2025
G2154: Folate Testing - Effective Date: 04-01-2025
G2154: Folate Testing - Effective Date: 06-01-2025
G2155: General Inflammation Testing - Effective Date: 02-01-2024
G2155: General Inflammation Testing - Effective Date: 04-01-2025
G2156: Urine Culture Testing for Bacteria - Effective Date: 02-01-2024
G2156: Urine Culture Testing for Bacteria - Effective Date: 04-01-2025
G2157: Diagnostic Testing of Common Sexually Transmitted Infections - Effective Date: 10-01-2022 to 09-30-2023
G2158: Testing for Vector-Borne Infections - Effective Date: 02-01-2024
G2158: Testing for Vector-Borne Infections - Effective Date: 04-01-2025
G2159: B-Hemolytic Streptococcus Testing - Effective Date: 05-01-2024
G2159: B-Hemolytic Streptococcus Testing - Effective Date: 04-01-2025
G2161: Hormonal Testing in Adult Females - Effective Date: 07-01-2021 to 05-31-2022
G2164: Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing - Effective Date: 12-01-2023
G2164: Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing - Effective Date: 08-01-2024
G2173: Gamma-glutamyl Transferase - Effective Date: 02-01-2024
G2173: Gamma-glutamyl Transferase Testing in Adults - Effective Date: 04-01-2025
G2174: Coronavirus Testing in the Outpatient Setting - Effective Date: 06-01-2024
G2174: Coronavirus Testing in the Outpatient Setting - Effective Date: 06-01-2025
G2181: Colorectal Cancer Screening - Effective Date: 08-01-2024
G2181: Colorectal Cancer Screening; efd 04-01-2025
M2041: Venous and Arterial Thrombosis Risk Testing - Effective Date: 12-01-2023
M2041: Venous and Arterial Thrombosis Risk Testing - Effective Date: 04-01-2025
M2057: Diagnosis of Vaginitis - Effective Date: 06-01-2024
M2057: Diagnosis of Vaginitis - Effective Date: 08-01-2024
M2058: Genetic Testing for Adolescent Idiopathic Scoliosis - Effective Date: 01-01-2023 to 11-30-2023
M2067: Therapeutic Drug Monitoring for 5-Fluorouracil - Effective Date: 06-01-2025
M2068: Testing for Alpha-1 Antitrypsin Deficiency - Effective Date: 02-01-2024
M2068: Testing for Alpha-1 Antitrypsin Deficiency - Effective Date: 04-01-2025
M2093: HIV Genotyping and Phenotyping - Effective Date: 01-01-2023 to 11-30-2023
M2097: Identification of Microorganisms Using Nucleic Acid Probes - Effective Date: 02-01-2024
M2097: Identification of Microorganisms Using Nucleic Acid Probes - Effective Date: 04-01-2025
M2112: Nerve Fiber Density Testing - Effective Date: 05-01-2024
M2112: Nerve Fiber Density Testing - Effective Date: 04-01-2025
M2116: Human Immunodefiency Virus (HIV) - Effective Date: 12-01-2023
M2116: Human Immunodeficiency Virus (HIV) - Effective Date: 08-01-2024
M2136: DNA Ploidy Cell Cycle Analysis - Effective Date: 08-01-2022 to 09-30-2022
M2141: Testing of Homocysteine Metabolism-Related Conditions - Effective Date: 06-01-2024
M2141: Testing of Homocysteine Metabolism-Related Conditions - Effective Date: 06-01-2025
M2172: Onychomycosis Testing - Effective Date: 12-01-2023
M2172: Onychomycosis Testing - Effective Date: 08-01-2024
M2176: Testing for Autism Spectrum Disorder and Developmental Delay - Effective Date: 06-01-2024
M2176: Testing for Developmental Delay - Effective Date: 06-01-2025
P2018: Immunohistochemistry - Effective Date: 06-01-2024
P2018: Immunohistochemistry - Effective Date: 06-01-2025
R2162: Laboratory Procedures Reimbursement Policy - Effective Date: 08-01-2022
R2162: Laboratory Procedures Reimbursement Policy - Effective Date: 06-01-2025
T2015: Prescription Medication and Illicit Drug Testing in the Outpatient Setting - Effective Date: 02-01-2024
T2015: Prescription Medication and Illicit Drug Testing in the Outpatient Setting - Effective Date: 08-01-2024
